HER2 Nanoparticle Safety and Specificity Data Presented at AACR 2019

Marie Zhang, PhD, Vice President of Research and Clinical Development at Imagion Biosystems, presented the poster "HER2 Functionalized Nanoparticles Are Safe…


MagSense™ Pre-Clinical Safety Data from AACR 2018

Pre-clinical data on Imagion Biosystems' MagSense HER2+ cancer detection platform have shown: specific binding and detection of HER2+ tumor cells in vitro…


Late-Breaking MagSense™ Safety Study Abstract Accepted for AACR 2018

Imagion Biosystems' abstract "Detection of HER2+ tumor cells using MagSense™ nanoparticles: safety and sensitivity" has been accepted for the 2018 AACR meeting…


Pre-clinical Data Presented at the 2017 World Medical Imaging Congress Move MagSense™ Closer to the Clinic

"Specific Detection of HER-2 positive tumors in mice using superparamagnetic relaxometry" is the title of a poster presented by Erika Vreeland, PhD, at the…


HER-2 Positive Tumor Detection at Tech Connect World Innovation Conference

This year's Tech Connect World Innovation Conference featured the poster "Superparamagnetic relaxometry (SPMR) for sensitive detection of HER-2 positive tumors…


Magnetic Relaxometry at the 2017 AACR Meeting

This year's Annual Meeting of the American Association for Cancer Research was held April 1-5 in Washington, D.C. The theme of this year's meeting was…